Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
2
×
chronic migraine
2
×
clinical trials
eli lilly
fda
indiana
indiana blog main
2
×
indiana top stories
life sciences
national blog main
teva pharmaceutical
alprazolam
boston blog main
calcitonin gene-related peptide
cgrp inhibitors
colucid pharmaceuticals
drug enforcement administration
drugs
episodic migraine
lasmiditan
migraine
migraine research foundation
raleigh-durham blog main
raleigh-durham top stories
the institute for clinical and economic review
triptans
What
approval
drug
2
×
eli
2
×
fda
lilly
migraine
new
won
acute
addresses
announced
approved
causes
class
condition
decades
decision
developed
friday
giant
giving
headache
lasmiditan
late
lilly’s
marks
medication
medicines
oks
pain
pharmaceutical
prevent
second
starts
thursday
Language
unset
Current search:
eli
×
drug
×
" indiana blog main "
×
biotech
×
" chronic migraine "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines